127 related articles for article (PubMed ID: 30731236)
1. Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life.
Phyo AZZ; Jelinek GA; Brown CR; O'Kearney E; Neate SL; De Livera AM; Taylor KL; Bevens W; Simpson S; Weiland TJ
Mult Scler Relat Disord; 2019 May; 30():25-32. PubMed ID: 30731236
[TBL] [Abstract][Full Text] [Related]
2. Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Jelinek GA; Weiland TJ; Hadgkiss EJ; Marck CH; Pereira N; van der Meer DM
Neurol Res; 2015 Aug; 37(8):662-73. PubMed ID: 25905471
[TBL] [Abstract][Full Text] [Related]
3. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients.
Simone IL; Ceccarelli A; Tortorella C; Bellacosa A; Pellegrini F; Plasmati I; De Caro MF; Lopez M; Girolamo F; Livrea P
Health Qual Life Outcomes; 2006 Dec; 4():96. PubMed ID: 17163989
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.
Janardhan V; Bakshi R
J Neurol Sci; 2002 Dec; 205(1):51-8. PubMed ID: 12409184
[TBL] [Abstract][Full Text] [Related]
5. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
Hadjimichael O; Vollmer T; Oleen-Burkey M;
Health Qual Life Outcomes; 2008 Nov; 6():100. PubMed ID: 19014588
[TBL] [Abstract][Full Text] [Related]
6. Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran.
Kargarfard M; Eetemadifar M; Mehrabi M; Maghzi AH; Hayatbakhsh MR
Eur J Neurol; 2012 Mar; 19(3):431-7. PubMed ID: 21967324
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.
Janardhan V; Bakshi R
Arch Neurol; 2000 Oct; 57(10):1485-91. PubMed ID: 11030802
[TBL] [Abstract][Full Text] [Related]
8. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
[TBL] [Abstract][Full Text] [Related]
9. Impact of depression, fatigue and disability on quality of life in Chinese patients with multiple sclerosis.
Chen K; Fan Y; Hu R; Yang T; Li K
Stress Health; 2013 Apr; 29(2):108-12. PubMed ID: 22566371
[TBL] [Abstract][Full Text] [Related]
10. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Drulovic J; Bursac LO; Milojkovic D; Tepavcevic DK; Gazibara T; Pekmezovic T
Disabil Rehabil; 2013 Mar; 35(5):362-6. PubMed ID: 22897503
[TBL] [Abstract][Full Text] [Related]
11. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
Ozakbas S; Akdede BB; Kösehasanogullari G; Aksan O; Idiman E
J Neurol Sci; 2007 May; 256(1-2):30-4. PubMed ID: 17379247
[TBL] [Abstract][Full Text] [Related]
12. Predictors of moderate to severe fatigue 12 months following admission to hospital for burn: Results from the Burns Registry of Australia and New Zealand (BRANZ) Long Term Outcomes project.
Gabbe BJ; Cleland H; Watterson D; Schrale R; McRae S; Taggart S; Darton A; Wood F; Edgar DW;
Burns; 2016 Dec; 42(8):1652-1661. PubMed ID: 28341091
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability.
Göksel Karatepe A; Kaya T; Günaydn R; Demirhan A; Ce P; Gedizlioğlu M
Int J Rehabil Res; 2011 Dec; 34(4):290-8. PubMed ID: 21946317
[TBL] [Abstract][Full Text] [Related]
14. Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis.
Sevim S; Kaleağası H; Taşdelen B
Mult Scler Relat Disord; 2017 Aug; 16():40-43. PubMed ID: 28755683
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis.
Jelinek GA; De Livera AM; Marck CH; Brown CR; Neate SL; Taylor KL; Weiland TJ
BMC Neurol; 2016 Nov; 16(1):235. PubMed ID: 27876009
[TBL] [Abstract][Full Text] [Related]
16. The role of psychological well‑being in multiple sclerosis rehabilitation.
Fanciullacci C; Straudi S; Basaglia N; Chisari C
Eur J Phys Rehabil Med; 2017 Feb; 53(1):105-113. PubMed ID: 27406880
[TBL] [Abstract][Full Text] [Related]
17. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet.
Weiland TJ; Jelinek GA; Marck CH; Hadgkiss EJ; van der Meer DM; Pereira NG; Taylor KL
PLoS One; 2015; 10(2):e0115541. PubMed ID: 25692993
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies.
Mäurer M; Comi G; Freedman MS; Kappos L; Olsson TP; Wolinsky JS; Miller AE; Dive-Pouletty C; Bozzi S; O'Connor PW
Mult Scler Relat Disord; 2016 May; 7():33-40. PubMed ID: 27237754
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients.
Putzki N; Katsarava Z; Vago S; Diener HC; Limmroth V
Eur Neurol; 2008; 59(3-4):136-42. PubMed ID: 18057900
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status.
Miller A; Dishon S
Qual Life Res; 2006 Mar; 15(2):259-71. PubMed ID: 16468081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
